Sandostatin and blood potassium decreased Patient Reports February 11, 2012

Sandostatin Side Effects Report #5888881-6
Sandostatin side effect was reported by a Consumer or non-health professional from CANADA on Sept 11, 2008. Female patient was diagnosed with neuroendocrine tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: alopecia, asthenia, blood glucose abnormal, blood potassium decreased, blood pressure decreased, blood sodium decreased, bone density decreased, cachexia, calcium ionised decreased. Sandostatin dosage: 30 MG, QMO. During the same period patient was treated with SANDOSTATIN LAR, SANDOSTATIN LAR. Patient was hospitalized and became disabled. Patient recovered.

Sandostatin Side Effects Report #5897762-3
Sandostatin side effect was reported by a Consumer or non-health professional from CANADA on Sept 18, 2008. Female patient was diagnosed with neuroendocrine tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: alopecia, asthenia, blood glucose abnormal, blood potassium decreased, blood pressure decreased, blood sodium decreased, bone density decreased, cachexia, calcium ionised decreased. Sandostatin dosage: 30 MG, QMO. During the same period patient was treated with SANDOSTATIN LAR, SANDOSTATIN LAR. Patient was hospitalized and became disabled. Patient recovered.

Sandostatin Side Effects Report #4768223-X
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 12, 2005. Female patient, weighting 126.6 lb, was diagnosed with neoplasm and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time shortened, arrhythmia supraventricular, blood magnesium increased, blood potassium decreased, blood urea increased, carbon dioxide decreased, cardiac telemetry abnormal, creatine phosphokinase decreased, dizziness . Sandostatin dosage: unknown. During the same period patient was treated with RADIATION, LASIX. Patient was hospitalized. Patient recovered.

Sandostatin Side Effects Report #4868035-2
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 23, 2005. Female patient, weighting 151.3 lb, was diagnosed with neoplasm and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , blood potassium decreased, blood urea increased, dehydration, diarrhoea, gallbladder disorder, nausea , small intestinal obstruction. Sandostatin dosage: unknown. During the same period patient was treated with SANDOSTATIN LAR, NORVASC, ASPIRIN, DETROL, DIAZIDE. Patient was hospitalized. Patient recovered.


Sandostatin Side Effects Report #5855926-9
Sandostatin side effect was reported by a Health Professional from CANADA on Aug 14, 2008. Female patient was diagnosed with gastrinoma and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: blood electrolytes abnormal, blood potassium decreased, diarrhoea, nausea , upper gastrointestinal haemorrhage. Sandostatin dosage: 20 MG, QMO. Patient was hospitalized. Patient recovered.

Sandostatin Side Effects Report #5877035-5
Sandostatin side effect was reported by a Health Professional from CANADA on Sept 02, 2008. Female patient was diagnosed with gastrinoma and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: blood electrolytes abnormal, blood potassium decreased, diarrhoea, nausea , upper gastrointestinal haemorrhage. Sandostatin dosage: 20 MG, QMO. Patient was hospitalized. Patient recovered.

Sandostatin Side Effects Report #5894938-6
Sandostatin side effect was reported by a Health Professional from CANADA on Sept 17, 2008. Female patient was diagnosed with gastrinoma and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: blood electrolytes abnormal, blood potassium decreased, diabetes mellitus, diarrhoea, nausea , upper gastrointestinal haemorrhage. Sandostatin dosage: 20 MG EVERY 4 WEEKS. Patient was hospitalized. Patient recovered.

Sandostatin Side Effects Report #5920334-9
Sandostatin side effect was reported by a Health Professional from CANADA on Oct 07, 2008. Female patient was diagnosed with gastrinoma and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: blood electrolytes abnormal, blood potassium decreased, diabetes mellitus, diarrhoea, nausea , upper gastrointestinal haemorrhage. Sandostatin dosage: 20 MG EVERY 4 WEEKS. Patient was hospitalized. Patient recovered.

Sandostatin Side Effects Report #5982552-3
Sandostatin side effect was reported by a Health Professional from CANADA on Nov 26, 2008. Female patient was diagnosed with gastrinoma and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: blood electrolytes abnormal, blood potassium decreased, diabetes mellitus, diarrhoea, hyperglycaemia, hypertension, nausea , upper gastrointestinal haemorrhage. Sandostatin dosage: 30 MG EVERY 4 WEEKS. Patient was hospitalized. Patient recovered.


Sandostatin Side Effects Report #5988742-8
Sandostatin side effect was reported by a Health Professional from CANADA on Dec 03, 2008. Female patient was diagnosed with gastrinoma and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: blood electrolytes abnormal, blood potassium decreased, diabetes mellitus, diarrhoea, hyperglycaemia, hypertension, nausea , upper gastrointestinal haemorrhage. Sandostatin dosage: 30 MG, QMO. Patient was hospitalized. Patient recovered.

Sandostatin Side Effects Report #6063097-1
Sandostatin side effect was reported by a Health Professional from CANADA on Jan 29, 2009. Female patient was diagnosed with gastrinoma and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: blood electrolytes abnormal, blood potassium decreased, diabetes mellitus, diarrhoea, hyperglycaemia, hypertension, nausea , upper gastrointestinal haemorrhage. Sandostatin dosage: 30 MG, QMO. Patient was hospitalized. Patient died on 01/01/2009.

Sandostatin Side Effects Report #5866312-X
Sandostatin side effect was reported by a Physician from JAPAN on Aug 26, 2008. Male patient was diagnosed with diarrhoea, graft versus host disease and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: blood potassium decreased, bradycardia, cardiac arrest , electrocardiogram st segment depression, haemoglobin decreased, hyperglycaemia, liver function test abnormal, loss of consciousness, scintigraphy. Sandostatin dosage: unknown. During the same period patient was treated with PROGRAF, NEUTROGIN, METHYLPREDNISOLONE SUCCINATE, METHYLPREDNISOLONE SUCCINATE, METHYLPREDNISOLONE SUCCINATE, HUMULIN R. Patient recovered.

Sandostatin Side Effects Report #5874487-1
Sandostatin side effect was reported by a Physician from JAPAN on Aug 26, 2008. Male patient was diagnosed with diarrhoea, graft versus host disease and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood potassium decreased, bradycardia, cardiac arrest , electrocardiogram st segment depression, haemoglobin decreased, hyperglycaemia, liver function test abnormal, loss of consciousness. Sandostatin dosage: unknown. During the same period patient was treated with PROGRAF, NEUTROGIN, METHYLPREDNISOLONE SUCCINATE, METHYLPREDNISOLONE SUCCINATE, METHYLPREDNISOLONE SUCCINATE, HUMULIN R. Patient recovered.

Sandostatin Side Effects Report #5967689-7
Sandostatin side effect was reported by a Physician from JAPAN on Nov 20, 2008. Male patient was diagnosed with diarrhoea, graft versus host disease and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood potassium decreased, bradycardia, cardiac arrest , electrocardiogram st segment depression, haemoglobin decreased, hyperglycaemia, liver function test abnormal, loss of consciousness. Sandostatin dosage: unknown. During the same period patient was treated with PROGRAF, NEUTROGIN, METHYLPREDNISOLONE SUCCINATE, METHYLPREDNISOLONE SUCCINATE, METHYLPREDNISOLONE SUCCINATE, HUMULIN R. Patient recovered.


Sandostatin Side Effects Report #4944976-2
Sandostatin side effect was reported by a Physician from UNITED STATES on Oct 18, 2005. Female patient, 65 years of age, weighting 140.0 lb, was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: application site pain, blood potassium decreased, diarrhoea, eating disorder , fatigue, flushing, haemoglobin decreased, occult blood positive, platelet count decreased. Sandostatin dosage: 20 MG; 30 MG; 40 MG, QMO, INJECTION NOS. During the same period patient was treated with SANDOSTATIN LAR, SANDOSTATIN LAR, INTRON, SYNTHROID, FOLIC ACID, LIPITOR, VITAPLEX. Patient recovered.

Sandostatin Side Effects Report #5403622-4
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2007. Female patient, 64 years of age, weighting 104.0 lb, was diagnosed with carcinoid syndrome, nausea  and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , ascites, asthenia, back pain , blood glucose increased, blood potassium decreased, chills, chronic obstructive pulmonary disease. Sandostatin dosage: 30 MG EVERY 28 DAYS. During the same period patient was treated with CLORAZEPATE, AMBIEN, REGLAN, NAPROSYN, PLAVIX, LISINOPRIL, TRIAMTERENE, VITAMIN D. Patient recovered.

Sandostatin Side Effects Report #5627090-2
Sandostatin side effect was reported by a Physician from UNITED STATES on Sept 24, 2007. Female patient, 47 years of age, was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: anorexia, arrhythmia , atrial tachycardia, back pain , blood glucose decreased, blood potassium decreased, cardiac flutter, dyspepsia. Sandostatin dosage: 20, 30 MG QMO, INTRAMUSCULAR. During the same period patient was treated with POTASSIUM, VITAMINS, TUMS. Patient recovered.

Sandostatin Side Effects Report #5289090-4
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 30, 2006. Female patient was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: anorexia, arrhythmia , back pain , blood glucose decreased, blood potassium decreased, dyspepsia, feeling cold, muscle spasms. Sandostatin dosage: unknown. During the same period patient was treated with SANDOSTATIN LAR, SANDOSTATIN LAR, SANDOSTATIN LAR, VITAMINS. Patient recovered.